Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 969.15M | 982.39M | 999.89M | 1.02B | -170.35M |
| Total Depreciation and Amortization | 4.33M | 3.50M | 3.29M | 3.07M | 3.10M |
| Total Amortization of Deferred Charges | 3.18M | 3.18M | 2.36M | 2.36M | 2.36M |
| Total Other Non-Cash Items | -14.84M | -12.21M | 171.42M | 150.17M | -364.30K |
| Change in Net Operating Assets | -1.15M | 16.31M | -47.03M | -23.64M | -8.11M |
| Cash from Operations | 960.66M | 993.17M | 1.13B | 1.16B | -173.36M |
| Capital Expenditure | -5.71M | -5.02M | -2.56M | -2.03M | -1.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -443.77M | -348.36M | -267.30M | -1.03B | -794.16M |
| Cash from Investing | -449.48M | -353.38M | -269.86M | -1.03B | -795.95M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -24.83M | -19.83M | -18.43M | -17.19M | -16.59M |
| Issuance of Common Stock | 46.61M | 48.61M | 32.07M | 35.27M | 7.05B |
| Repurchase of Common Stock | -407.17M | -407.17M | -407.17M | -603.21M | -351.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00K | -2.46M | -213.63M |
| Cash from Financing | -58.95M | -57.86M | -60.18M | -88.03M | 932.14M |
| Foreign Exchange rate Adjustments | 3.08M | -7.79M | -8.75M | -25.66M | -57.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 455.30M | 574.14M | 791.14M | 11.20M | -37.23M |